arrow
G

Giorgio Lorenzo Colombo

University of Pavia
H指数:23
被引数:3,198

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cost-Effectiveness of Elranatamab Versus Teclistamab for the Management of Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma in Italy

与Teclistamab相比,Elranatamab在意大利用于管理三药类暴露的复发/难治性多发性骨髓瘤患者的成本效益。

Cancers
IF4.4
2026-04-030
OAAI
U-CHANGE Project: a multidimensional consensus on how clinicians, patients and caregivers may approach together the new urothelial cancer scenario

U-change项目: 关于临床医生,患者和护理人员如何共同处理新的尿路上皮癌方案的多维共识

2023-07-282
OAAI
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
2019-01-0193
OAAI
Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation

人重组卵泡刺激素 (rFSH) 与尿人绝经期促性腺激素 (HMG) 在辅助生殖中卵巢刺激的比较: 文献综述和成本评估

2014-12-0615
OAAI
The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres (vol 27, pg 1292, 2012)
2014-06-035
OAAI
The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres
2012-03-14786
OA